{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:03:49Z","timestamp":1789430629003,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T00:00:00Z","timestamp":1213315200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s10928-008-9087-3","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T14:16:24Z","timestamp":1213280184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Onset dynamics of type A botulinum neurotoxin-induced paralysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Frank J.","family":"Lebeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Chushak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,13]]},"reference":[{"key":"9087_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","volume":"285","author":"SS Arnon","year":"2001","unstructured":"Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O\u2019Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 285: 1059\u20131070","journal-title":"JAMA"},{"key":"9087_CR2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/S0041-0101(01)00157-X","volume":"39","author":"EA Johnson","year":"2001","unstructured":"Johnson EA, Bradshaw M (2001) Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. Toxicon 39: 1703\u20131722","journal-title":"Toxicon"},{"key":"9087_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","volume":"44","author":"LL Simpson","year":"2004","unstructured":"Simpson LL (2004) Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 44: 167\u2013193","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9087_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1124\/jpet.106.104661","volume":"318","author":"E Ravichandran","year":"2006","unstructured":"Ravichandran E, Gong Y, Al Saleem FH, Ancharski DM, Joshi SG, Simpson LL (2006) An initial assessment of the systemic pharmacokinetics of botulinum toxin. J Pharmacol Exp Ther 318: 1343\u20131351","journal-title":"J Pharmacol Exp Ther"},{"key":"9087_CR5","first-page":"373","volume-title":"Chemical warfare agents: toxicity at low levels","author":"M Adler","year":"2000","unstructured":"Adler M, Oyler G, Keller JE, Lebeda FJ (2000) Pharmacological countermeasures for botulinum intoxication. In: Somani SM, Romano JA(eds) Chemical warfare agents: toxicity at low levels. CRC Press, Boca Raton, pp 373\u2013391"},{"key":"9087_CR6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/1-59259-764-5:255","volume-title":"Biological weapons defense: principles and mechanisms of infectious diseases and counterbioterrorism","author":"CB Millard","year":"2005","unstructured":"Millard CB (2005) Medical defense against protein toxin weapons. In: Lindler L, Lebeda FJ, Korch G(eds) Biological weapons defense: principles and mechanisms of infectious diseases and counterbioterrorism. Humana Press Inc, Totowa, pp 255\u2013283"},{"key":"9087_CR7","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.2174\/0929867043363802","volume":"11","author":"KR Aoki","year":"2004","unstructured":"Aoki KR (2004) Botulinum toxin: a successful therapeutic protein. Curr Med Chem 11: 3085\u20133092","journal-title":"Curr Med Chem"},{"key":"9087_CR8","unstructured":"Public Law Project BioShield Act of 2004, 108\u201376, 118 Stat 835. Government Printing Office, Washington, DC (2004)"},{"key":"9087_CR9","unstructured":"US Department of Health and Human Services, Project BioShield: Medical countermeasures for botulism (2007) http:\/\/www.hhs.gov\/aspr\/barda\/mcm\/botulism.html. Accessed 14 March 2008"},{"key":"9087_CR10","unstructured":"US Department of Health and Human Services, HHS awards BioShield contract for botulism antitoxin (2006) http:\/\/www.hhs.gov\/news\/press\/2006pres\/20060601.html. Accessed 14 March 2008"},{"issue":"8","key":"9087_CR11","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1002\/mds.20023","volume":"19","author":"JD Marks","year":"2004","unstructured":"Marks JD (2004) Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization. Mov Disord 19(8): S101\u2013108","journal-title":"Mov Disord"},{"key":"9087_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.embor.7400796","volume":"7","author":"C Verderio","year":"2006","unstructured":"Verderio C, Rossetto O, Grumelli C, Frassoni C, Montecucco C, Matteoli M (2006) Entering neurons: botulinum toxins and synaptic vesicle recycling. EMBO Reports 7: 995\u2013999","journal-title":"EMBO Reports"},{"key":"9087_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/15569549909036017","volume":"18","author":"FJ Lebeda","year":"1999","unstructured":"Lebeda FJ, Singh BR (1999) Membrane channel activity and translocation of tetanus and botulinum neurotoxins. J Toxicol Toxin Rev 18: 45\u201376","journal-title":"J Toxicol Toxin Rev"},{"key":"9087_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","volume":"80","author":"G Schiavo","year":"2000","unstructured":"Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80: 717\u2013766","journal-title":"Physiol Rev"},{"key":"9087_CR15","first-page":"16","volume":"212","author":"LL Simpson","year":"1980","unstructured":"Simpson LL (1980) Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 212: 16\u201321","journal-title":"J Pharmacol Exp Ther"},{"key":"9087_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0041-0101(02)00086-7","volume":"40","author":"KR Aoki","year":"2002","unstructured":"Aoki KR (2002) Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety. Toxicon 40: 923\u2013928","journal-title":"Toxicon"},{"key":"9087_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.neuroscience.2005.12.029","volume":"139","author":"JE Keller","year":"2006","unstructured":"Keller JE (2006) Recovery from botulinum neurotoxin poisoning in\u00a0vivo. Neuroscience 139: 629\u2013637","journal-title":"Neuroscience"},{"key":"9087_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000083259","volume":"53","author":"D Dressler","year":"2005","unstructured":"Dressler D, Adib Saberi F (2005) Botulinum toxin: mechanisms of action. Eur Neurol 53: 3\u20139","journal-title":"Eur Neurol"},{"key":"9087_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0041-0101(82)90183-0","volume":"20","author":"JO Dolly","year":"1982","unstructured":"Dolly JO, Williams RS, Black JD, Tse CK, Hambleton P, Melling J (1982) Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomes. Toxicon 20: 141\u2013148","journal-title":"Toxicon"},{"key":"9087_CR20","volume-title":"Enzyme kinetics","author":"IH Segel","year":"1975","unstructured":"Segel IH (1975) Enzyme kinetics. Wiley-Interscience, New York"},{"key":"9087_CR21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0026-895X(25)13525-6","volume":"14","author":"M Adler","year":"1978","unstructured":"Adler M, Albuquerque EX, Lebeda FJ (1978) Kinetic analysis of end plate currents altered by atropine and scopolamine. Mol Pharmacol 14: 514\u2013529","journal-title":"Mol Pharmacol"},{"key":"9087_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF00755401","volume":"5","author":"JJ Hablitz","year":"1985","unstructured":"Hablitz JJ, Lebeda FJ (1985) Role of uptake in gamma-aminobutyric acid (GABA)-mediated responses in guinea pig hippocampal neurons. Cell Mol Neurobiol 5: 353\u2013371","journal-title":"Cell Mol Neurobiol"},{"key":"9087_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/0028-3908(74)90014-8","volume":"13","author":"LL Simpson","year":"1974","unstructured":"Simpson LL (1974) Studies on the binding of botulinum toxin type A to the rat phrenic nerve-hemidiaphragm preparation. Neuropharmacology 13: 683\u2013691","journal-title":"Neuropharmacology"},{"key":"9087_CR24","volume-title":"Botulinum toxin therapy","author":"D Dressler","year":"2000","unstructured":"Dressler D (2000) Botulinum toxin therapy. Georg Thieme Verlag, Stutgard"},{"key":"9087_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/153623103322637670","volume":"7","author":"HM Sauro","year":"2003","unstructured":"Sauro HM, Hucka M, Finney A, Wellock C, Bolouri H, Doyle J, Kitano H. (2003) Next generation simulation tools: the systems biology workbench and BioSPICE integration. OMICS 7: 355\u2013372","journal-title":"OMICS"},{"key":"9087_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/(SICI)1097-4547(19960501)44:3<263::AID-JNR7>3.0.CO;2-E","volume":"44","author":"PU Daniels-Holgate","year":"1996","unstructured":"Daniels-Holgate PU, Dolly JO (1996) Productive and non-productive binding of botulinum neurotoxin A to motor nerve endings are distinguished by its heavy chain. J Neurosci Res 44: 263\u2013271","journal-title":"J Neurosci Res"},{"key":"9087_CR27","volume-title":"Kinetics of fast enzyme reactions","author":"K Hiromi","year":"1979","unstructured":"Hiromi K (1979) Kinetics of fast enzyme reactions. John Wiley and Sons, New York"},{"key":"9087_CR28","first-page":"143","volume-title":"The receptors: a comprehensive treatise","author":"A De Lean","year":"1979","unstructured":"De Lean A, Rodbard D (1979) Kinetics of cooperative binding. In: O\u2019Brien RD (ed) The receptors: a comprehensive treatise. Plenum Press, New York, pp 143\u2013192"},{"key":"9087_CR29","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1001\/jama.296.20.2476","volume":"296","author":"DS Chertow","year":"2006","unstructured":"Chertow DS, Tan ET, Maslanka SE, Schulte J, Bresnitz EA, Weisman RS, Bernstein J, Marcus SM, Kumar S, Malecki J, Sobel J, Braden CR (2006) Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA 296: 2476\u20132479","journal-title":"JAMA"},{"key":"9087_CR30","doi-asserted-by":"publisher","first-page":"9725","DOI":"10.1021\/bi0494673","volume":"43","author":"BC Yowler","year":"2004","unstructured":"Yowler BC, Schengrund CL (2004) Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b. Biochemistry 43: 9725\u20139731","journal-title":"Biochemistry"},{"key":"9087_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","volume":"51","author":"A Rummel","year":"2004","unstructured":"Rummel A, Mahrhold S, Bigalke H, Binz T (2004) The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol Microbiol 51: 631\u2013643","journal-title":"Mol Microbiol"},{"key":"9087_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1123654","volume":"312","author":"M Dong","year":"2006","unstructured":"Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312: 592\u2013596","journal-title":"Science"},{"key":"9087_CR33","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","volume":"580","author":"S Mahrhold","year":"2006","unstructured":"Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T (2006) The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580: 2011\u20132014","journal-title":"FEBS Lett"},{"key":"9087_CR34","volume-title":"Binding and linkage: functional chemistry of biological macromolecules","author":"J Wyman","year":"1990","unstructured":"Wyman J, Gill SJ (1990) Binding and linkage: functional chemistry of biological macromolecules. University Science Books, Mill Valley"},{"key":"9087_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0041-0101(94)00183-9","volume":"33","author":"M Adler","year":"1995","unstructured":"Adler M, Scovill J, Parker G, Lebeda FJ, Piotrowski J, Deshpande SS (1995) Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations. Toxicon 33: 527\u2013537","journal-title":"Toxicon"},{"key":"9087_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nsb879","volume":"10","author":"LK Koriazova","year":"2003","unstructured":"Koriazova LK, Montal M (2003) Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 10: 13\u201318","journal-title":"Nat Struct Biol"},{"key":"9087_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1023\/A:1026386710428","volume":"16","author":"JJ Schmidt","year":"1997","unstructured":"Schmidt JJ, Bostian KA (1997) Endoproteinase activity of type A botulinum neurotoxin: substrate requirements and activation by serum albumin. J Protein Chem 16: 19\u201326","journal-title":"J Protein Chem"},{"key":"9087_CR38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0041-0101(01)00082-4","volume":"39","author":"CV Jurasinski","year":"2001","unstructured":"Jurasinski CV, Lieth E, Dang Do AN, Schengrund CL (2001) Correlation of cleavage of SNAP-25 with muscle function in a rat model of Botulinum neurotoxin type A induced paralysis. Toxicon 39: 1309\u20131315","journal-title":"Toxicon"},{"key":"9087_CR39","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0022-3565(24)38842-1","volume":"296","author":"S Kalandakanond","year":"2001","unstructured":"Kalandakanond S, Coffield JA (2001) Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc. J Pharmacol Exp Ther 296: 980\u2013986","journal-title":"J Pharmacol Exp Ther"},{"key":"9087_CR40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S1044-7431(02)00016-7","volume":"22","author":"FA Meunier","year":"2003","unstructured":"Meunier FA, Lisk G, Sesardic D, Dolly JO (2003) Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation. Mol Cell Neurosci 22: 454\u2013466","journal-title":"Mol Cell Neurosci"},{"key":"9087_CR41","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1086\/508176","volume":"43","author":"S Kongsaengdao","year":"2006","unstructured":"Kongsaengdao S, Samintarapanya K, Rusmeechan S, Wongsa A, Pothirat C, Permpikul C, Pongpakdee S, Puavilai W, Kateruttanakul P, Phengtham U, Panjapornpon K, Janma J, Piyavechviratana K, Sithinamsuwan P, Deesomchok A, Tongyoo S, Vilaichone W, Boonyapisit K, Mayotarn S, Piya-Isragul B, Rattanaphon A, Intalapaporn P, Dusitanond P, Harnsomburana P, Laowittawas W, Chairangsaris P, Suwantamee J, Wongmek W, Ratanarat R, Poompichate A, Panyadilok H, Sutcharitchan N, Chuesuwan A, Oranrigsupau P, Sutthapas C, Tanprawate S, Lorsuwansiri J, Phattana N (2006) An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure. Clin Infect Dis 43: 1247\u20131256","journal-title":"Clin Infect Dis"},{"key":"9087_CR42","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1099\/0022-1317-51-11-978","volume":"51","author":"JA Jones","year":"2002","unstructured":"Jones JA, Salmon JE, Djuretic T, Nichols G, George RC, Gill ON, Brazier JS, Brett MM, Duerden BI, Fry NK, Hall V, Hope V, Lieftucht A, McLauchlin J, Pitcher DG, Weild A (2002) An outbreak of serious illness and death among injecting drug users in England during 2000. J Med Microbiol 51: 978\u2013984","journal-title":"J Med Microbiol"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-008-9087-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-008-9087-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-008-9087-3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-008-9087-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T12:53:47Z","timestamp":1738241627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10928-008-9087-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9087"],"URL":"https:\/\/doi.org\/10.1007\/s10928-008-9087-3","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"19 December 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"251"}}